Encompass Health Q4 adjusted EPS rises 24.8% to USD 1.46

Reuters
02/06
Encompass Health Q4 adjusted EPS rises 24.8% to USD 1.46

Encompass Health Corporation reported its results for the fourth quarter (Q4) of 2025. Net operating revenue for Q4 2025 was USD 1.54 billion, reflecting a 9.9% increase. Net income attributable to shareholders for the period was USD 146.1 million. Diluted earnings per share from continuing operations reached USD 1.42, with a 20.3% increase, while adjusted earnings per share were USD 1.46, up by 24.8%. Cash flows provided by operating activities for the quarter totaled USD 346.0 million. The company also issued its 2026 guidance, projecting adjusted earnings per share attributable to Encompass Health in the range of USD 5.81 to USD 6.10. Supplemental information and additional details regarding the quarter and outlook are available on the company’s investor relations website. Encompass Health remains the largest owner and operator of inpatient rehabilitation hospitals in the United States.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Encompass Health Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CL80977) on February 05, 2026, and is solely responsible for the information contained therein.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10